One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
This complete historical IV source is not a contemporary AUC, neonatal, unstable-AKI or high-flux-HD dosing algorithm. Its low-flux statement must not be generalized to modern HD. Original nomogram calculations and target concentrations are not enabled as automated recommendations.
The 2015 RX label mirror preserves an older steady-state renal nomogram and anuric approach. The 2020 multi-society executive summary favors AUC-guided monitoring for serious invasive MRSA, rather than reliance on trough surrogates or a fixed renal estimate alone.
What to reconcile: Use measured exposure, current renal function and the actual dialysis prescription with local monitoring capability. The consensus target is indication-scoped and is not a new fixed dose, oral-vancomycin rule or universal replacement-therapy schedule.
Open this note and its source referencesThis historical source requires renal adjustment and serum-concentration monitoring. Its adult nomogram approximates a daily dose in mg as 15 times renal clearance, but requires a valid steady-state estimate and explicitly excludes functionally anephric patients. The source also describes older long-interval anuric regimens. Those historical approaches must not be generalized to modern high-flux dialysis or used as a substitute for exposure-guided monitoring. The complete local comparison includes the later serious-MRSA consensus perspective. Kidney-function changes, indication, body size and measured drug exposure require reassessment rather than blind reuse of this old nomogram.
RDM40-rxlist-vancomycin-0f611c0f73-C1 · Source locator: Selected renal dosing, renal impairment, toxicity and pharmacokinetic subsections as identified in the summary.
Imported for attributed historical context. No obsolete anuric interval is promoted as a current default.
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=vancomycin&s1=RDM40-rxlist-vancomycin-0f611c0f73&h1=ce0d2e16db3c05cf7467010cbd301543c0c667371903a06339c9506fbbd9e988